UA111191C2 - Макролідне похідне, заміщене по с-4"-положенню - Google Patents

Макролідне похідне, заміщене по с-4"-положенню Download PDF

Info

Publication number
UA111191C2
UA111191C2 UAA201311232A UAA201311232A UA111191C2 UA 111191 C2 UA111191 C2 UA 111191C2 UA A201311232 A UAA201311232 A UA A201311232A UA A201311232 A UAA201311232 A UA A201311232A UA 111191 C2 UA111191 C2 UA 111191C2
Authority
UA
Ukraine
Prior art keywords
group
compound
formula
reference example
added
Prior art date
Application number
UAA201311232A
Other languages
English (en)
Ukrainian (uk)
Inventor
Томохіро Сугімото
Наокі Сасамото
Дзун КУРОСАКА
Масато Хаясі
Канако ЯМАМОТО
Масато Касімура
Ясунобу Усікі
Харухіса Огіта
Томоакі Міура
Кеніті Канемото
Коу КУМУРА
Сатосі Йосіда
Кейдзі Тамура
Єїкі Сітара
Original Assignee
Тайсо Фармасьютікал Ко., Лтд.
Мейдзі Сейка Фарма Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46721028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA111191(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Тайсо Фармасьютікал Ко., Лтд., Мейдзі Сейка Фарма Ко., Лтд. filed Critical Тайсо Фармасьютікал Ко., Лтд.
Publication of UA111191C2 publication Critical patent/UA111191C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
UAA201311232A 2011-02-21 2012-02-20 Макролідне похідне, заміщене по с-4"-положенню UA111191C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011034578 2011-02-21
PCT/JP2012/054677 WO2012115256A1 (en) 2011-02-21 2012-02-20 C-4" position substituted macrolide derivative

Publications (1)

Publication Number Publication Date
UA111191C2 true UA111191C2 (uk) 2016-04-11

Family

ID=46721028

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201311232A UA111191C2 (uk) 2011-02-21 2012-02-20 Макролідне похідне, заміщене по с-4"-положенню

Country Status (34)

Country Link
US (1) US9139609B2 (US07794700-20100914-C00152.png)
EP (1) EP2678349B1 (US07794700-20100914-C00152.png)
JP (1) JP5687777B2 (US07794700-20100914-C00152.png)
KR (1) KR20140008388A (US07794700-20100914-C00152.png)
CN (1) CN103492404B (US07794700-20100914-C00152.png)
AR (1) AR085286A1 (US07794700-20100914-C00152.png)
AU (1) AU2012222267B2 (US07794700-20100914-C00152.png)
BR (1) BR112013020118A2 (US07794700-20100914-C00152.png)
CA (1) CA2827474A1 (US07794700-20100914-C00152.png)
CL (1) CL2013002313A1 (US07794700-20100914-C00152.png)
CO (1) CO6801737A2 (US07794700-20100914-C00152.png)
CY (1) CY1117381T1 (US07794700-20100914-C00152.png)
DK (1) DK2678349T3 (US07794700-20100914-C00152.png)
ES (1) ES2566368T3 (US07794700-20100914-C00152.png)
HR (1) HRP20160252T1 (US07794700-20100914-C00152.png)
HU (1) HUE028245T2 (US07794700-20100914-C00152.png)
IL (1) IL227663A (US07794700-20100914-C00152.png)
IN (1) IN2013CN07459A (US07794700-20100914-C00152.png)
ME (1) ME02475B (US07794700-20100914-C00152.png)
MX (1) MX2013009585A (US07794700-20100914-C00152.png)
MY (1) MY161451A (US07794700-20100914-C00152.png)
NZ (1) NZ613956A (US07794700-20100914-C00152.png)
PE (1) PE20140649A1 (US07794700-20100914-C00152.png)
PL (1) PL2678349T3 (US07794700-20100914-C00152.png)
RS (1) RS54635B1 (US07794700-20100914-C00152.png)
RU (1) RU2599718C2 (US07794700-20100914-C00152.png)
SA (1) SA112330287B1 (US07794700-20100914-C00152.png)
SG (1) SG192655A1 (US07794700-20100914-C00152.png)
SI (1) SI2678349T1 (US07794700-20100914-C00152.png)
SM (1) SMT201600106B (US07794700-20100914-C00152.png)
TW (1) TWI513704B (US07794700-20100914-C00152.png)
UA (1) UA111191C2 (US07794700-20100914-C00152.png)
WO (1) WO2012115256A1 (US07794700-20100914-C00152.png)
ZA (1) ZA201305983B (US07794700-20100914-C00152.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
CN109748942A (zh) * 2014-05-16 2019-05-14 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) * 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 C-4"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN108610388B (zh) * 2016-12-12 2020-11-06 浙江京新药业股份有限公司 一种大环内酯的制备方法
CN109425666B (zh) * 2017-08-28 2022-07-08 广东东阳光药业有限公司 一种酰氯衍生物的lc-ms分析方法
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
TW202126649A (zh) 2019-09-26 2021-07-16 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物
CN111423482B (zh) * 2020-04-26 2023-01-17 梯尔希(南京)药物研发有限公司 一种同位素标记的红霉胺的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5393743A (en) 1993-07-06 1995-02-28 Abbott Laboratories Erythromycin derivatives
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
RU2144541C1 (ru) * 1995-12-08 2000-01-20 Руссель Юклаф Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
ATE296308T1 (de) * 1996-09-04 2005-06-15 Abbott Lab 6-o-substituierte ketoliden mit antibakteriellen wirkung
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
SK15162001A3 (sk) * 1999-05-24 2003-02-04 Pfizer Products Inc. Deriváty 13-metylerytromycínu
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
WO2008106226A2 (en) * 2007-02-28 2008-09-04 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
US20080203485A1 (en) 2007-02-28 2008-08-28 International Business Machines Corporation Strained metal gate structure for cmos devices with improved channel mobility and methods of forming the same

Also Published As

Publication number Publication date
AU2012222267B2 (en) 2016-07-07
CY1117381T1 (el) 2017-04-26
SA112330287B1 (ar) 2015-10-11
EP2678349A4 (en) 2014-07-30
RU2599718C2 (ru) 2016-10-10
JP5687777B2 (ja) 2015-03-18
SMT201600106B (it) 2016-04-29
TWI513704B (zh) 2015-12-21
CL2013002313A1 (es) 2014-08-08
MX2013009585A (es) 2014-06-05
SI2678349T1 (sl) 2016-04-29
RU2013142898A (ru) 2015-03-27
SG192655A1 (en) 2013-09-30
BR112013020118A2 (pt) 2017-07-18
RS54635B1 (en) 2016-08-31
IL227663A0 (en) 2013-09-30
CA2827474A1 (en) 2012-08-30
US9139609B2 (en) 2015-09-22
MY161451A (en) 2017-04-14
IN2013CN07459A (US07794700-20100914-C00152.png) 2015-04-24
PE20140649A1 (es) 2014-06-25
TW201247693A (en) 2012-12-01
EP2678349B1 (en) 2016-01-13
NZ613956A (en) 2014-07-25
AU2012222267A1 (en) 2013-08-22
IL227663A (en) 2017-09-28
HRP20160252T1 (hr) 2016-04-22
WO2012115256A1 (en) 2012-08-30
ES2566368T3 (es) 2016-04-12
ZA201305983B (en) 2014-11-26
ME02475B (me) 2017-02-20
CO6801737A2 (es) 2013-11-29
DK2678349T3 (en) 2016-03-07
JP2014505723A (ja) 2014-03-06
EP2678349A1 (en) 2014-01-01
HUE028245T2 (en) 2016-12-28
CN103492404B (zh) 2016-09-07
AR085286A1 (es) 2013-09-18
US20140046043A1 (en) 2014-02-13
PL2678349T3 (pl) 2016-06-30
KR20140008388A (ko) 2014-01-21
CN103492404A (zh) 2014-01-01

Similar Documents

Publication Publication Date Title
UA111191C2 (uk) Макролідне похідне, заміщене по с-4"-положенню
EP2077271A1 (en) Macrolide derivative
US8354383B2 (en) 6,11-bridged biaryl macrolides
KR20050003454A (ko) 6,11 바이사이클릭 에리스로마이신 유도체
KR101223158B1 (ko) 6,11-다리걸친 바이아릴 매크로라이드
SK284607B6 (sk) Trinásťčlenné azalidy, spôsob ich výroby, farmaceutická kompozícia obsahujúca tieto azalidy a ich použitie ako antibiotiká
JP5857008B2 (ja) C−4”位置換マクロライド誘導体を含有する医薬
CN101166749A (zh) 6-11桥联的肟乙基琥珀酸红霉素酯衍生物
US8299035B2 (en) 10a-azalide compound having 4-membered ring structure
US8293715B2 (en) 10a-Azalide compound crosslinked at 10a- and 12-positions